Phenoxpen

COMPOSITIONS :

Each film coated tablet contains :

THERAPEUTIC PROPERTIES

It is an antibiotic from the beta-lactam family, in the group of natural penicillin , specifically phenoxymethylpenicillins.

INDICATIONS

Indications are limited to infections caused by organisms defined as sensitive (see Pharmacodynamics):

Curative use:
– Documented sore throat caused by group A beta-hemolytic streptococcus.
– Mild skin infections caused by sensitive organisms.
Prophylaxis:
– Prevention of relapses of Acute Rheumatic Fever (ARF).
– Prevention of recurring erysipelas.
– For contact persons in the vicinity of a case of scarlet fever.
– Pneumococcal infections in splenectomized patients, major sickle cell patients, and other functionally asplenic individuals

IN CASE OF DOUBT, IT IS ESSENTIAL TO CONSULT YOUR DOCTOR OR PHARMACIST.

WARNING AND PRECAUTION :

Allergic reactions: Fever, hives, angioedema, and, rarely, anaphylactic shock.
Gastrointestinal disorders: Nausea, vomiting, diarrhea, and black tongue in case of prolonged treatment.
Hematological reactions (reversible): Anemia, thrombocytopenia, leukopenia, coagulation disorders.

Curative treatment:
The daily dosage should be divided into 2 to 3 doses for sore throats, or 3 to 4 doses for other indications.
• Adult: 2,000,000 to 4,000,000 IU/day.
• Infants and children up to 40 kg: 50,000 to 100,000 IU/kg/day.
Treatment duration: For sore throats, treatment should last for 10 days.
Prophylaxis:
The daily dosage should be divided into two doses.
• Infants and children:
• Up to 10 kg: 100,000 IU/kg/day.
• From 10 kg to 40 kg: 50,000 IU/kg/day, without exceeding 2,000,000 IU/day.
• Adults: 2,000,000 IU/day; prophylaxis should continue for at least 2 years after splenectomy

CONSERVATION